Profile for Israel Patent: 272723
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Israel Patent: 272723
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Get Started Free | Apr 19, 2038 | Abbvie | ORILISSA | elagolix sodium |
| ⤷ Get Started Free | Aug 20, 2038 | Abbvie | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium |
| ⤷ Get Started Free | Aug 20, 2038 | Abbvie | ORILISSA | elagolix sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
